Daily Stock Analysis, HTGM, HTG Molecular Diagnostics Inc, priceseries

HTG Molecular Diagnostics Inc. Daily Stock Analysis
Stock Information
Open
1.55
Close
1.52
High
1.58
Low
1.52
Previous Close
1.55
Daily Price Gain
-0.03
YTD High
3.24
YTD High Date
Apr 10, 2019
YTD Low
1.44
YTD Low Date
Jul 2, 2019
YTD Price Change
-1.18
YTD Gain
-43.70%
52 Week High
5.46
52 Week High Date
Sep 28, 2018
52 Week Low
1.44
52 Week Low Date
Jul 2, 2019
52 Week Price Change
-1.66
52 Week Gain
-52.20%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 1. 2017
3.17
Mar 2. 2017
3.33
1 Trading Days
5.21%
Link
LONG
Mar 3. 2017
2.81
Mar 7. 2017
3.45
2 Trading Days
22.60%
Link
LONG
Mar 23. 2017
3.93
Apr 4. 2017
6.11
8 Trading Days
55.39%
Link
LONG
Oct 10. 2017
1.89
Oct 31. 2017
2.36
15 Trading Days
25.10%
Link
LONG
Dec 21. 2017
1.90
Jan 17. 2018
3.09
16 Trading Days
62.66%
Link
LONG
Feb 12. 2018
4.05
Feb 27. 2018
4.67
10 Trading Days
15.24%
Link
LONG
Aug 24. 2018
3.39
Sep 12. 2018
4.15
12 Trading Days
22.46%
Link
Company Information
Stock Symbol
HTGM
Exchange
NasdaqCM
Company URL
http://www.htgmolecular.com
Company Phone
877-289-2615
CEO
Timothy B. Johnson
Headquarters
Arizona
Business Address
3430 E. GLOBAL LOOP, TUCSON, AZ 85706
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001169987
About

HTG Molecular Diagnostics, Inc. provides molecular technology solutions. It offers products for miRNA, and mRNA measurement for translational research/medicine and molecular diagnostics. Its qNPA molecular technology platform detects changes in gene expression levels; especially from formalin-fixed, paraffin-embedded tissue and other biological sample types. It also offers pharma and diagnostics services. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Description

HTG Molecular Diagnostics, Inc. develops and markets technology platforms that facilitate the routine use of complex molecular profiling. The company's HTG Edge and HTG EdgeSeq platforms consist of instrumentation, consumables, and software analytics that are used in molecular profiling applications, including tumor profiling, biomarker development and prospectively, and molecular diagnostic testing. The company's platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on various biological samples. It provides molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States and Europe; and through distributors or sales agents in parts of Europe and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.